GOTHENBURG, Sweden, Jan. 5, 2024 /PRNewswire/ -- Zinzino group total revenue increased 23% in Q4 and total revenue for the full year 2023 increased 23%, compared to the previous year.

The revenue in December for Zinzino's sales markets increased by 23 % and amounted to SEK 152.4 (123.8) million. Faun Pharma's external sales decreased and amounted to SEK 5.0 (5.1) million. Overall, the Group increased revenues by 22% to SEK 157.4 (128.9) million compared with the previous year.

Sales in Zinzino's sales markets increased by 24% in the fourth quarter of 2023 compared with the same period last year and amounted to SEK 511.2 (413.3) million. Total revenues in the Group increased by 23 % in the fourth quarter and amounted to SEK 529.8 (429.3) million.

Accumulated revenue for January - December 2023 increased by 23% to SEK 1768.3 (1443.1) million.

Revenues were distributed as follows:

                 Regions, mSEK 23-Dec 22-Dec  Change   Q4 2023   Q4 2022    Change     YTD 2023     YTD 2022      Change



     The Nordics                26.7    34.3    -22 %      82.9       90.9       -9 %        300.0         326.6         -8 %



     Central Europe             43.3    27.8     56 %     134.9       94.3       43 %        437.9         290.8         51 %



     East Europe                32,0    27,0     19 %     113.0      103.4        9 %        394.3         341.2         16 %



     South & West Europe        25,0    14.9     68 %      86.8       50.6       72 %        267,0         164.6         62 %



     The Baltics                 8.4     7.2     17 %      31.5       25.3       24 %         98.3          77.9         26 %



     North America              10.6     5.6     89 %      43.0       25.2       71 %        110.8          77.2         44 %



     Asia-Pacific                5.5     5.8     -5 %      15.8       19.8      -20 %         56.8          77.5        -27 %



     Africa                      0.9     1.2    -25 %       3.2        3.8      -15 %         13.2          10,0         32 %



     
              Zinzino        152.4   123.8     23 %     511.2      413.3       24 %       1678.3        1365.8         23 %



     Faun Pharma                 5,0     5.1     -2 %      18.7       16,0       17 %         90,0          77.3         16 %


                 Zinzino Group  157.4   128.9     22 %     529.8      429.3       23 %       1768.3        1443.1         23 %

Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge:
marketing@zinzino.com

Certified Adviser:
Carnegie Investment Bank AB (publ)

The following files are available for download:


     
     https://mb.cision.com/Public/10976/3904387/ba2a14ebb95c44cd.pdf 2312 Pressrelease
                                                                         Salesreport EN

View original content:https://www.prnewswire.co.uk/news-releases/zinzino-ab-publ-preliminary-sales-report-2023-302027063.html

Tags

More Like This

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q3 2023

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q3 2024

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT NOVEMBER 2023

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT JANUARY 2024

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT OCTOBER 2023

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q1 2024

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT MAY 2024

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT FEBRUARY 2024